Insider sentiment is turning bearish (30-day S/B Ratio 2.1) as selling outpaces buying by 2.5 to 1 this past week. However, there are still opportunities for investors as we’ve upgraded three stocks, including a waste management company (RSG +N), an energy producer (COP +N), and a computer hardware company (NSIT +1), with insider buying in the latter while it’s near a multi-year […]
Insight Enterprises (NSIT, +1, Feb 21th) Timothy Crown (Co-Founder, Chair since 2005, CEO 1994-2005) purchased $127,000 of stock on the 16th of February at $127.32, increasing his stake by 1%. Whilst relatively modest in size to his holdings and his historic sales, It is however notable as only his 3rd ever purchase despite a very […]
Centene Corp (CNC, +1, Feb 13th) Drew Asher (CFO since May 2021; joined Jan. 2020) purchased 6,800 shares on February 10th at $71.93, spending $490,000 and increasing his holdings to 315,000 shares. This is Asher’s first purchase in CNC. He joined in 2020 with the merger of Wellcare Health Plans where he was CFO, and […]
Intevac Inc (IVAC, +1, Feb 9th) Nigel Hunton (CEO since 2022) purchased $70,000 of stock across two trades in February 2023 at an average price of $6.98, increasing his stake by 4%. He made a series of smaller trades having joined in 2022 and it’s notable to see him now buying in larger size at […]
Charter Communication Inc – (CHTR, +1, Feb 2nd) Steven Miron (Director since 2016) purchased 2,500 shares on January 31st at $384, spending $961,000 and increasing his holdings to 9,173 shares. Despite his 6+ year tenure on this board as well as a 9 year tenure on the board of Warner Bros Discovery (WBD), this is […]
PNC Financial Services Group Inc – (PNC, +1, Jan 25th) William Demchak (Chairman & CEO since 2014, joined company as CFO in 2002) purchased 6,550 shares on January 20th at $153.38, spending $1,004,639. The trade is both his first purchase since 2009 (which was well-timed) and also a reversal from a sale at a similar […]
EOG Resources Inc – (EOG, +1, January 18th) Michael Kerr (Non Executive since 2020) purchased $2.6 million of stock on the 12th January at $130.49, increasing his stake by 12%. His only previous purchase was for $4.3m of stock in November 2021 at $86 which we ranked +N reflecting his likely long history following the […]
We did not rank any new stocks this week and therefore are using an upgrade from January 5th, Lovesac (LOVE +N) for the stock of the week. Note that a month ago we downgraded RH (RH -N on Dec. 9th), a much larger and more established competitor but both stocks have had >-60% declines from […]
Merrimack Pharmaceutical Inc – (MACK, +1, January 4th) Eric Andersen (Non-Executive since 2019) bought $2.8 million of stock on the 30th of December at $10.67, increasing his stake by 20%. The purchases were indirect and on behalf of Western Standard, they now own 11.4% of the outstanding shares. They made a series of purchases into […]
Harrow Health Inc – (HROW, +1, Dec 23rd) Four insiders bought a total of $725,000 of stock on the 21-22nd December at approx $13.40. Most notably Mark Baum (CEO since 2012, founder) bought $325,000 increasing his stake by 2% in his first clean purchase on record despite a long tenure and Martin Makary (Non-Executive since […]